Jupiter Neurosciences, Inc. SEC filings JUNS
Jupiter Neurosciences, Inc. has 203 filings in SEC EDGAR's recent list, going back to Jul 15, 2016. Its latest annual report, Form ARS, was filed on Jun 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 3, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 27, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 24, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jul 27, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 21, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 21, 2026 | May 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 20, 2026 | May 20, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Feb 27, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 20, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 23, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Dec 22, 2025 | Dec 19, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Nov 20, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Oct 27, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Other events
|
Jul 10, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 21, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 25, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 19, 2024 | Dec 15, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 4, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 19, 2024 | Nov 15, 2024 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JUNS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jupiter, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1679628
- Former names
- Jupiter Orphan Therapeutics, Inc. (until Dec 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.